{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:11:53Z","timestamp":1779297113176,"version":"3.51.4"},"reference-count":71,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>The vaccine strains against influenza virus A\/H3N2 for the 2010-2011 season and influenza virus B for the 2009-2010 and 2010-2011 seasons in Japan are a high-growth reassortant A\/Victoria\/210\/2009 (X-187) strain and an egg-adapted B\/Brisbane\/60\/2008 (Victoria lineage) strain, respectively.  Hemagglutination inhibition (HI) tests with postinfection ferret antisera indicated that the antisera raised against the X-187 and egg-adapted B\/Brisbane\/60\/2008 vaccine production strains poorly inhibited recent epidemic isolates of MDCK-grown A\/H3N2 and B\/Victoria lineage viruses, respectively. The low reactivity of the ferret antisera may be attributable to changes in the hemagglutinin (HA) protein of production strains during egg adaptation. To evaluate the efficacy of A\/H3N2 and B vaccines, the cross-reactivities of postvaccination human serum antibodies against A\/H3N2 and B\/Victoria lineage epidemic isolates were assessed by a comparison of the geometric mean titers (GMTs) of HI and neutralization (NT) tests. Serum antibodies elicited by the X-187 vaccine had low cross-reactivity to both MDCK- and egg-grown A\/H3N2 isolates by HI test and narrow cross-reactivity by NT test in all age groups. On the other hand, the GMTs to B viruses detected by HI test were below the marginal level, so the cross-reactivity was assessed by NT test. The serum neutralizing antibodies elicited by the B\/Brisbane\/60\/2008 vaccine reacted well with egg-grown B viruses but exhibited remarkably low reactivity to MDCK-grown B viruses. The results of these human serological studies suggest that the influenza A\/H3N2 vaccine for the 2010-2011 season and B vaccine for the 2009-2010 and 2010-2011 seasons may possess insufficient efficacy and low efficacy, respectively.<\/jats:p>","DOI":"10.1128\/cvi.05726-11","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T03:22:50Z","timestamp":1333596170000},"page":"897-908","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":32,"title":["Evaluation of Influenza Virus A\/H3N2 and B Vaccines on the Basis of Cross-Reactivity of Postvaccination Human Serum Antibodies against Influenza Viruses A\/H3N2 and B Isolated in MDCK Cells and Embryonated Hen Eggs"],"prefix":"10.1128","volume":"19","author":[{"given":"Noriko","family":"Kishida","sequence":"first","affiliation":[{"name":"Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Fujisaki","sequence":"additional","affiliation":[{"name":"Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Laboratory of Viral Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Sato","sequence":"additional","affiliation":[{"name":"Laboratory of Viral Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Public Health, Niigata University School of Medicine, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Ikematsu","sequence":"additional","affiliation":[{"name":"Center for Advanced Medical Innovation, Kyusyu University, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[{"name":"Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Takashita","sequence":"additional","affiliation":[{"name":"Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Takao","sequence":"additional","affiliation":[{"name":"Center for Public Health and Environment, Hiroshima Prefectural Technology Research Institute, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Yano","sequence":"additional","affiliation":[{"name":"Mie Prefecture Health and Environment Research Institute, Mie, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Suga","sequence":"additional","affiliation":[{"name":"Kobe Institute of Health, Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Yokohama City Institute of Health, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Hiroshima City Institute of Public Health, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kajiyama","sequence":"additional","affiliation":[{"name":"Fukuoka City Institute for Hygiene and the Environment, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Saito","sequence":"additional","affiliation":[{"name":"Akita Prefectural Research Center for Public Health and Environment, Akita, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin'ichi","family":"Shimada","sequence":"additional","affiliation":[{"name":"Saitama Institute of Public Health, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Ehime Prefecture Institute of Public Health and Environmental Science, Ehime, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Taira","sequence":"additional","affiliation":[{"name":"Okinawa Prefectural Institute of Health and Environment, Okinawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyako","family":"Kon","sequence":"additional","affiliation":[{"name":"Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jih-Hui","family":"Lin","sequence":"additional","affiliation":[{"name":"Center for Research and Diagnostics, Centers for Disease Control, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Odagiri","sequence":"additional","affiliation":[{"name":"Laboratory of Influenza Virus Surveillance, Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.5.4472-4477.1998"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.vaccine.2012.02.003","article-title":"Intanza(\u00ae) 15 intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses","volume":"30","author":"Ansaldi F","year":"2012","unstructured":"AnsaldiF. 2012. Intanza(\u00ae) 15 intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses. Vaccine 30:2908\u20132913.","journal-title":"Vaccine"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/infdis\/153.4.805","article-title":"Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderly","volume":"153","author":"Arden NH","year":"1986","unstructured":"ArdenNH. 1986. Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderly. J. Infect. Dis. 153:805\u2013806.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.28.3.753-761.1980"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(75)90720-5","article-title":"Trials in man with live recombinants made from A\/PR\/8\/34 (H0 N1) and wild H3 N2 influenza viruses","author":"Beare AS","year":"1975","unstructured":"BeareASSchildGCCraigJW. 1975. Trials in man with live recombinants made from A\/PR\/8\/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet ii:729\u2013732.","journal-title":"Lancet"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe RB","year":"2007","unstructured":"BelsheRB. 2007. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356:685\u2013696.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000185883","article-title":"Effect of immunomodulator thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis","volume":"54","author":"Beyer WE","year":"1990","unstructured":"BeyerWE. 1990. Effect of immunomodulator thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis. Nephron 54:296\u2013301.","journal-title":"Nephron"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.1016\/j.vaccine.2010.08.064","article-title":"An influenza B outbreak during the 2007\/2008 winter among appropriately immunized elderly people living in a nursing home","volume":"28","author":"Camilloni B","year":"2010","unstructured":"CamilloniB. 2010. An influenza B outbreak during the 2007\/2008 winter among appropriately immunized elderly people living in a nursing home. Vaccine 28:7536\u20137541.","journal-title":"Vaccine"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.vaccine.2007.11.013","article-title":"Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs","volume":"26","author":"Chen Z","year":"2008","unstructured":"ChenZAspelundAJinH. 2008. Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs. Vaccine 26:361\u2013371.","journal-title":"Vaccine"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00149-3"},{"key":"e_1_3_2_12_2","unstructured":"Committee for Medicinal Products for Human Use (CHMP). 1997. Note for guidance on harmonization of requirements for influenza vaccines. European Agency for the Evaluation of Medicinal Products Brussels Belgium."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/124.5.473","article-title":"Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man","volume":"124","author":"Couch RB","year":"1971","unstructured":"CouchRBDouglasRGJrFedsonDSKaselJA. 1971. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J. Infect. Dis. 124:473\u2013480.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"D233","DOI":"10.1093\/nar\/gki057","article-title":"The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema","volume":"33","author":"Deshpande N","year":"2005","unstructured":"DeshpandeN. 2005. The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema. Nucleic Acids Res. 33:D233\u2013D237.","journal-title":"Nucleic Acids Res."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nsb0298-119","article-title":"Antigen distortion allows influenza virus to escape neutralization","volume":"5","author":"Fleury D","year":"1998","unstructured":"FleuryDWhartonSASkehelJJKnossowMBizebardT. 1998. Antigen distortion allows influenza virus to escape neutralization. Nat. Struct. Biol. 5:119\u2013123.","journal-title":"Nat. Struct. Biol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/viro.1999.9732","article-title":"Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses","volume":"258","author":"Gambaryan AS","year":"1999","unstructured":"GambaryanASRobertsonJSMatrosovichMN. 1999. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 258:232\u2013239.","journal-title":"Virology"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/172.1.1","article-title":"Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine","volume":"172","author":"Gorse GJ","year":"1995","unstructured":"GorseGJ. 1995. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J. Infect. Dis. 172:1\u201310.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/oxfordjournals.aje.a112029","article-title":"An outbreak of an influenza type A variant in a closed population: the effect of homologous and heterologous antibody on infection and illness","volume":"100","author":"Greenberg SB","year":"1974","unstructured":"GreenbergSBCouchRBKaselJA. 1974. An outbreak of an influenza type A variant in a closed population: the effect of homologous and heterologous antibody on infection and illness. Am. J. Epidemiol. 100:209\u2013215.","journal-title":"Am. J. Epidemiol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/viro.1994.1100","article-title":"Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation","volume":"199","author":"Gubareva LV","year":"1994","unstructured":"GubarevaLV. 1994. Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation. Virology 199:89\u201397.","journal-title":"Virology"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2004.02.025"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1995.1405","article-title":"Egg fluids and cells of the chorioallantoic membrane of embryonated chicken eggs can select different variants of influenza A (H3N2) viruses","volume":"211","author":"Hardy CT","year":"1995","unstructured":"HardyCTYoungSAWebsterRGNaeveCWOwensRJ. 1995. Egg fluids and cells of the chorioallantoic membrane of embryonated chicken eggs can select different variants of influenza A (H3N2) viruses. Virology 211:302\u2013306.","journal-title":"Virology"},{"key":"e_1_3_2_23_2","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson D","year":"1972","unstructured":"HobsonDCurryRLBeareASWard-GardnerA. 1972. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.) 70:767\u2013777.","journal-title":"J. Hyg. (Lond.)"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-1702(97)00143-3","article-title":"Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin","volume":"53","author":"Imai M","year":"1998","unstructured":"ImaiMSugimotoKOkazakiKKidaH. 1998. Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin. Virus Res. 53:129\u2013139.","journal-title":"Virus Res."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1016\/j.vaccine.2006.05.037","article-title":"An influenza A\/H3 outbreak during the 2004\/2005 winter in elderly vaccinated people living in a nursing home","volume":"24","author":"Iorio AM","year":"2006","unstructured":"IorioAM. 2006. An influenza A\/H3 outbreak during the 2004\/2005 winter in elderly vaccinated people living in a nursing home. Vaccine 24:6615\u20136619.","journal-title":"Vaccine"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.1128\/JVI.74.19.9300-9305.2000","article-title":"Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks","volume":"74","author":"Ito T","year":"2000","unstructured":"ItoT. 2000. Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J. Virol. 74:9300\u20139305.","journal-title":"J. Virol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.4.1808-1811.1990"},{"issue":"5","key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-73-5-1159","article-title":"Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells","volume":"73","author":"Katz JM","year":"1992","unstructured":"KatzJMWebsterRG. 1992. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells. J. Gen. Virol. 73(Pt 5):1159\u20131165.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/160.2.191","article-title":"Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs","volume":"160","author":"Katz JM","year":"1989","unstructured":"KatzJMWebsterRG. 1989. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J. Infect. Dis. 160:191\u2013198.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0042-6822(82)90375-0","article-title":"Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A\/Seal\/Massachusetts\/1\/80 (H7N7) influenza virus","volume":"122","author":"Kida H","year":"1982","unstructured":"KidaHBrownLEWebsterRG. 1982. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A\/Seal\/Massachusetts\/1\/80 (H7N7) influenza virus. Virology 122:38\u201347.","journal-title":"Virology"},{"issue":"7","key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1099\/0022-1317-74-7-1311","article-title":"Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A\/Shanghai\/11\/87 (H3N2) virus selected as high yield reassortants","volume":"74","author":"Kilbourne ED","year":"1993","unstructured":"KilbourneED. 1993. Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A\/Shanghai\/11\/87 (H3N2) virus selected as high yield reassortants. J. Gen. Virol. 74(Pt 7):1311\u20131316.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.111.3.387"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/jcc.20933","article-title":"The generalized Born\/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area","volume":"29","author":"Labute P","year":"2008","unstructured":"LabuteP. 2008. The generalized Born\/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area. J. Comput. Chem. 29:1693\u20131698.","journal-title":"J. Comput. Chem."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S0022172400053596","article-title":"Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2)","volume":"80","author":"Larson HE","year":"1978","unstructured":"LarsonHETyrrellDABowkerCHPotterCWSchildGC. 1978. Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2). J. Hyg. (Lond.) 80:243\u2013248.","journal-title":"J. Hyg. (Lond.)"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1016\/j.vaccine.2006.05.063","article-title":"Real-time monitoring of the influenza vaccine field effectiveness","volume":"24","author":"Legrand J","year":"2006","unstructured":"LegrandJVerguEFlahaultA. 2006. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 24:6605\u20136611.","journal-title":"Vaccine"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1016\/j.vaccine.2006.05.062","article-title":"Single amino acid substitutions in the hemagglutinin of influenza A\/Singapore\/21\/04 (H3N2) increase virus growth in embryonated chicken eggs","volume":"24","author":"Lu B","year":"2006","unstructured":"LuBZhouHChanWKembleGJinH. 2006. Single amino acid substitutions in the hemagglutinin of influenza A\/Singapore\/21\/04 (H3N2) increase virus growth in embryonated chicken eggs. Vaccine 24:6691\u20136693.","journal-title":"Vaccine"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026335"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/viro.2001.1121","article-title":"Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes","volume":"289","author":"Medeiros R","year":"2001","unstructured":"MedeirosREscriouNNaffakhNManuguerraJCvan der WerfS. 2001. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology 289:74\u201385.","journal-title":"Virology"},{"issue":"55","key":"e_1_3_2_39_2","first-page":"12","article-title":"Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic","author":"Meiklejohn G","year":"1952","unstructured":"MeiklejohnGKempeCHThalmanWGLennetteEH. 1952. Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic. Am. J. Hyg. (Lond.) (55):12\u201321.","journal-title":"Am. J. Hyg. (Lond.)"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/viro.1993.1461","article-title":"Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses","volume":"196","author":"Meyer WJ","year":"1993","unstructured":"MeyerWJ. 1993. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses. Virology 196:130\u2013137.","journal-title":"Virology"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM196603102741001","article-title":"Immunity to influenza to antibody levels","volume":"274","author":"Morris JA","year":"1966","unstructured":"MorrisJAKaselJASaglamMKnightVLodaFA. 1966. Immunity to influenza to antibody levels. N. Engl. J. Med. 274:527\u2013535.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/08828240260066242","article-title":"Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines","volume":"15","author":"Murphy BR","year":"2002","unstructured":"MurphyBRCoelinghK. 2002. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol. 15:295\u2013323.","journal-title":"Viral Immunol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s007050170055","article-title":"Antigenic and genetic analyses of influenza B viruses isolated in Lusaka, Zambia in 1999","volume":"146","author":"Muyanga J","year":"2001","unstructured":"MuyangaJ. 2001. Antigenic and genetic analyses of influenza B viruses isolated in Lusaka, Zambia in 1999. Arch. Virol. 146:1667\u20131679.","journal-title":"Arch. Virol."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.7.3295-3297.2004"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/j.vaccine.2009.07.006","article-title":"Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy","volume":"27","author":"Nichol KL","year":"2009","unstructured":"NicholKL. 2009. Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. Vaccine 27:6305\u20136311.","journal-title":"Vaccine"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0679"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00398-08"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.5.2552-2558.1993"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/jp994072s","article-title":"Modification of the generalized Born model suitable for macromolecules","volume":"104","author":"Onufriev A","year":"2000","unstructured":"OnufrievABashfordDCaseDA. 2000. Modification of the generalized Born model suitable for macromolecules. J. Phys. Chem. B 104:3712\u20133720.","journal-title":"J. Phys. Chem. B"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virol.2009.01.005","article-title":"Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures","volume":"386","author":"Pekosz A","year":"2009","unstructured":"PekoszANewbyCBosePSLutzA. 2009. Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures. Virology 386:61\u201367.","journal-title":"Virology"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/bmj.4.5842.701","article-title":"Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response","volume":"4","author":"Pereira MS","year":"1972","unstructured":"PereiraMSChakravertyPSchildGCColemanMTDowdleWR. 1972. Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br. Med. J. 4:701\u2013703.","journal-title":"Br. Med. J."},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0065-3233(03)66002-X","article-title":"Force fields for protein simulations","volume":"66","author":"Ponder JW","year":"2003","unstructured":"PonderJWCaseDA. 2003. Force fields for protein simulations. Adv. Protein Chem. 66:27\u201385.","journal-title":"Adv. Protein Chem."},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S0022172400053158","article-title":"Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines","volume":"79","author":"Potter CW","year":"1977","unstructured":"PotterCWJenningsRNicholsonKTyrrellDADickinsonKG. 1977. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J. Hyg. (Lond.) 79:321\u2013332.","journal-title":"J. Hyg. (Lond.)"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","volume":"35","author":"Potter CW","year":"1979","unstructured":"PotterCWOxfordJS. 1979 Determinants of immunity to influenza infection in man. Br. Med. Bull. 35:69\u201375.","journal-title":"Br. Med. Bull."},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0042-6822(87)90040-7","article-title":"Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus","volume":"160","author":"Robertson JS","year":"1987","unstructured":"RobertsonJS. 1987. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology 160:31\u201337.","journal-title":"Virology"},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0042-6822(85)90105-9","article-title":"Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs","volume":"143","author":"Robertson JS","year":"1985","unstructured":"RobertsonJS. 1985. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology 143:166\u2013174.","journal-title":"Virology"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jmv.20178","article-title":"Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation","volume":"74","author":"Saito T","year":"2004","unstructured":"SaitoT. 2004. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J. Med. Virol. 74:336\u2013343.","journal-title":"J. Med. Virol."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040059"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2002.1719","article-title":"Reappearance and global spread of variants of influenza B\/Victoria\/2\/87 lineage viruses in the 2000-2001 and 2001-2002 seasons","volume":"303","author":"Shaw MW","year":"2002","unstructured":"ShawMW. 2002. Reappearance and global spread of variants of influenza B\/Victoria\/2\/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 303:1\u20138.","journal-title":"Virology"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nsmb.1497","article-title":"Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif","volume":"15","author":"Shirakawa K","year":"2008","unstructured":"ShirakawaK. 2008. Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat. Struct. Mol. Biol. 15:1184\u20131191.","journal-title":"Nat. Struct. Mol. Biol."},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1128\/JVI.00406-07","article-title":"A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas","volume":"81","author":"Song H","year":"2007","unstructured":"SongH. 2007. A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J. Virol. 81:7280\u20137285.","journal-title":"J. Virol."},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00058-10"},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archpedi.162.10.943","article-title":"Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study","volume":"162","author":"Szilagyi PG","year":"2008","unstructured":"SzilagyiPG. 2008. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch. Pediatr. Adolesc. Med. 162:943\u2013951.","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003942"},{"key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1099\/vir.0.80021-0","article-title":"Homology model of the structure of influenza B virus HA1","volume":"85","author":"Tung CS","year":"2004","unstructured":"TungCSGoodmanJLLuHMackenCA. 2004. Homology model of the structure of influenza B virus HA1. J. Gen. Virol. 85:3249\u20133259.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05619-11"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.9.7626-7631.1998"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/JVI.02477-07","article-title":"Crystal structure of unliganded influenza B virus hemagglutinin","volume":"82","author":"Wang Q","year":"2008","unstructured":"WangQChengFLuMTianXMaJ. 2008. Crystal structure of unliganded influenza B virus hemagglutinin. J. Virol. 82:3011\u20133020.","journal-title":"J. Virol."},{"key":"e_1_3_2_69_2","unstructured":"World Health Organization. 2011. Summary of status of development and availability of influenza B candidate vaccine viruses and potency testing reagents. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_70_2","volume-title":"Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. 2009. Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_71_2","volume-title":"Recommended composition of influenza virus vaccines for use in the 2010-2011 northern hemisphere influenza season","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. 2010. Recommended composition of influenza virus vaccines for use in the 2010-2011 northern hemisphere influenza season. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016650"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.05726-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.05726-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:47:18Z","timestamp":1627591638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.05726-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1128\/CVI.05726-11"],"URL":"https:\/\/doi.org\/10.1128\/cvi.05726-11","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"2012-01-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-03-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-05-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}